Beximco Pharmaceuticals Share Price (BXP)

0.00 0.00 (0.00%) delayed: 2:15AM BST
Bid price 51.00 Open price 0.00
Ask price 54.00 Prev close 52.50
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Beximco Pharmaceuticals share prices, Beximco Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Beximco Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Beximco Pharmaceuticals (BXP) and other London Stock Exchange equities.

Beximco Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Beximco Pharmaceuticals share price charts

Beximco Pharmaceuticals Share Price Information

Name Beximco Pharmaceuticals Epic BXP
Sector Pharmaceuticals & Biotechnology ISIN US0885792061
Activites Beximco Pharmaceuticals Limited was founded in 1976 and based in Dhaka, Bangladesh. Beximco Pharma manufactures and sells generic pharmaceutical formulation products and active pharmaceutical ingredients. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies. The Company operates from a 23 acre site in Dhaka and has manufacturing facilities for producing various drugs in different delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, prefilled syringes, injectables, nebuliser solutions, oral soluble films etc. Ensuring access to quality medicines is the powerful aspiration that motivates 3,500 employees of the Company. Beximco Pharma's state-of-the-art manufacturing facilities are certified by global regulatory authorities of USA, Europe, Australia, Canada, GCC and Latin America, among others. The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in South East Asia, including Singapore, Thailand, Taiwan, Malaysia, Indonesia, Philippines and Hong Kong; Africa, including South Africa, Mauritius, Kenya, Ghana, Ethiopia, Uganda and Nigeria; Central Asia, including Azerbaijan; Middle East, including Kuwait and Jordan; Pacific Island countries; Latin and Central American countries; Europe, including Austria, Germany and Romania; Australia and North America, including the USA and Canada. Index n/a

Beximco Pharmaceuticals Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 25.63
Market Capitalisation (£m) 212.92 Gross Gearing (%) 26.44
Shares in issue (m) 405.56 Debt Ratio 18.27
P/E Ratio 9.56 Debt-to-Equity Ratio 0.62
Total dividends per share (p) 1.25 Assets / Equity Ratio 1.36
Dividend Yield (%) 2.38 Price to book value 0.01
Dividend cover (x) 4.39 ROCE (%) 9.43
Earning per share (p) 5.49 EPS Growth (%) -28.05
52 week high / low 68.50 / 46.00 DPS Growth (%) 25.00

Beximco Pharmaceuticals Company News

07:00 30/07/2018

US FDA Approves Beximco Pharma's Nadolol Tablets

RNS Number : 0815W Beximco Pharmaceuticals Ltd 30 July 2018   30 July 2018       BEXIMCO PHARMACEUTICALS LTD.   US FDA approves Beximco Pharma's Nadolol tablets to treat high blood pressure and angina   Marks the Company's fifth product approval for...

08:28 23/07/2018

Beximco Pharmaceuticals exports fourth product to US

Generic pharmaceuticals manufacturer Beximco Pharmaceuticals said Monday it had exported its anti-diabetic drug to the US market. This was the fourth product Beximco Pharma had exported to the US market, the company said. Beximco Pharma received US Food and Drug Administration (FDA) approval...

07:00 23/07/2018

Commences export of fourth product to the US

RNS Number : 3601V Beximco Pharmaceuticals Ltd 23 July 2018   23 July 2018   BEXIMCO PHARMACEUTICALS LTD.   Beximco Pharma commences export of fourth product to the US   Beximco Pharmaceuticals Limited ("BPL", "Beximco Pharma" or "Company"; AIM Symbol:...

More Beximco Pharmaceuticals Company News >>

Register now for FREE Beximco Pharmaceuticals company news

Beximco Pharmaceuticals Share Price Discussions

more than 1 year ago

Asia's answer to bird flu (BXP)

BEXIMCO PHARMACEUTICALS LTD. News Release 23 March 2006 Beximco Pharmaceuticals Ltd introduces OsefluÒ to fight against the Bird Flu Leading drug manufacturer in Bangladesh Beximco Pharmaceuticals Limited introduced yesterday (March 22, 2006) Oseflu capsule for the prevention and treatment of...

Register now for FREE Beximco Pharmaceuticals share price discussions